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Abstract. In adipose and muscle cells, insulin stimu- 
lates a rapid and dramatic increase in glucose uptake, 
primarily by promoting the redistribution of the 
GLUT4 glucose transporter from its intracellular stor- 
age site to the plasma membrane. In contrast, the more 
ubiquitously expressed isoform GLUT1 is localized at 
the cell surface in the basal state, and shows a less dra- 
matic translocation in response to insulin. To identify 
sequences involved in the differential subcellular local- 
ization and hormone-responsiveness of these isoforms, 
chimeric GLUT1/GLUT4 transporters were stably ex- 
pressed in mouse 3T3-L1 adipocytes. The NH  2 termi- 
nus of GLUT4 contains sequences capable of seques- 
tering the transporter inside the cell, although not in an 
insulin-sensitive pool. In contrast, the COOH-terminal 
30 amino acids of GLUT4 are sufficient for its correct 
localization to an intraceUular storage pool which trans- 
locates to the cell surface in response to insulin. The 
dileucine motif within this domain, which is required 
for intracellular sequestration of chimeric transporters 
in fibroblasts, is not critical for targeting to the hor- 
mone-responsive compartment in adipocytes. Analysis 
of rates of internalization of chimeric transporter after 
the removal of insulin from cells, as well as the subcel- 
lular distribution of transporters in cells unexposed to 
or treated with insulin, leads to a three-pool model 
which can account for the data. 
LUCOSE uptake  into  mammalian  cells  is  accom- 
plished by a family of proteins, the facilitative glu- 
cose transporters, which differ in their tissue dis- 
tribution  and  physiological  roles.  Two  of the  isoforms 
identified to date, GLUT1 and GLUT4, are expressed in 
adipose and muscle, those tissues which exhibit a marked 
increase in glucose uptake in response to insulin (5). The 
differential localization of these  isoforms within the cell 
may contribute to their distinct functions. GLUT1, which 
is expressed in virtually all tissues, is distributed to both 
the plasma membrane and the interior of the cell in the 
basal state. Insulin causes a two- to fivefold increase in the 
amount of GLUT1 present at the cell surface, a recruit- 
ment similar to other recycling membrane proteins such as 
the insulin-like growth factor II and transferrin receptors 
(39).  GLUT4, which  is  expressed exclusively in  insulin- 
responsive cell types, is excluded from the plasma mem- 
brane and instead localizes to an intracellular storage pool 
in  the  basal  state.  Insulin  stimulates  the  specific  re- 
cruitment of these vesicles to the cell surface, increasing 
by 10- to 40-fold the amount of GLUT4 present at the cell 
surface, and  thereby dramatically increasing  the  hexose 
uptake capacity of the cell (8, 9, 21, 24, 34, 36-38, 49). 
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The  mechanisms  responsible  for the  insulin-regulated 
movement of GLUT4 in adipose and muscle may be simi- 
lar to those utilized by other cell types for regulated secre- 
tion. This is supported by the ability of GLUT4 to segre- 
gate  to large  dense core vesicles when  expressed in the 
neuroendocrine cell line PC12  (23). The involvement of 
members of the small G protein family is suggested by the 
ability of non-hydrolyzable GTP analogs to substitute for 
insulin in stimulating GLUT4 translocation (3, 31) and by 
the  cloning of an  adipocyte-specific homologue of rab3 
(rab3D;  reference 2).  Several other components of the 
regulated  secretion  machinery  have  been  identified  in 
adipocytes,  including  the  vesicle  associated  membrane 
protein, synaptobrevin (7), and the secretory carrier mem- 
brane proteins (26, 40). In addition, the specialized endo- 
some-related subcellular compartment to which GLUT4 is 
sequestered in adipocytes may be related to the compart- 
ment in  antigen-presenting  cells where major histocom- 
patibility complex class II molecules are loaded with their 
antigenic peptides (1, 41, 46). Insights into the trafficking 
of GLUT4 may also be applicable to the study of other 
regulatable transmembrane transporters. For example, the 
water channel aquaporin-2 is sequestered in intracellular 
vesicles and moves to the apical plasma membrane of re- 
nal collecting duct cells in response to the antidiuretic hor- 
mone vasopressin (13). 
The differential localization of GLUT1 and GLUT4 in 
insulin-responsive tissues has been reproduced in heterol- 
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duced (18,  23, 28, 35). This suggests that the GLUT1 and 
GLUT4 proteins  contain  within their primary sequences 
the information necessary to direct their differential sort- 
ing within the cell, and that many cell types are capable of 
recognizing these sequences.  Indeed, the construction  of 
chimeric GLUT1/GLUT4 transporters  and  their expres- 
sion in cultured cell lines has led to the identification of se- 
quences involved in differential sorting. Piper et al. have 
found the NH  2 terminus of GLUT4 necessary for the in- 
tracellular sequestration  of this isoform in Chinese  ham- 
ster ovary cells, and a Phe critical, presumably by affecting 
the  internalization  of GLUT4 from the  cell surface  (29, 
30).  However,  several  laboratories  have  concluded  that 
the primary targeting information resides in the COOH- 
terminal 30 amino acids of the transporters (11, 27, 43). In 
particular, a dileucine motif within this region is necessary 
for the intracellular sequestration of GLUT4 in fibroblasts 
(10,  42).  These  results  suggest  that  GLUT4,  and  not 
GLUT1, contains the actively recognized sorting informa- 
tion, as mutation of the dileucine motif altered the subcel- 
lular location of the mutant transporters to one that was 
indistinguishable from GLUT1. 
As informative as the previous studies  are,  none  have 
investigated the localization of the  chimeric transporters 
in the physiologically relevant cell types, muscle and adi- 
pose.  In  addition,  it  is  not  known  whether  the  signals 
which  confer intracellular  localization  of GLUT4 in  the 
basal state are sufficient to dictate its dramatic transloca- 
tion to the plasma membrane in response to insulin. To ad- 
dress these questions, we have utilized the mouse cell line 
3T3-L1, a derivative of Swiss 3T3 fibroblasts which differ- 
entiates  into  adipocyte-like  cells  under  the  appropriate 
culture conditions. These cells develop many of the char- 
acteristics  of authentic  adipose  cells,  including  marked, 
acute  insulin-responsive  glucose transport  (32).  GLUT1/ 
GLUT4  chimeric  transporters  were  stably  expressed  in 
3T3-L1 adipocytes and the subcellular localization of the 
transporters was determined in the basal and insulin-stim- 
ulated states. Our results suggest that chimeric transport- 
ers containing the NH2 terminus of GLUT4 are localized 
to the interior of the cell, although not in an insulin-sensi- 
tive compartment.  In  addition,  we  show  that  sequences 
within the COOH-terminal 30 amino acids of GLUT4, but 
not the dileucine motif, are required for the correct local- 
ization of chimeric transporters to an intracellular storage 
vesicle which is capable of translocating to the cell surface 
in response to insulin. 
Materials and Methods 
Materials 
Crystalline  porcine insulin was a  gift  from Lilly  Research Laboratories 
(Indianapolis, IN). 1251-protein A  was purchased from ICN Radiochemi- 
cals (Irvine, CA) and 2-[1,2-3H]deoxy-o-glucose  (30.6 Ci/mmol) from New 
England Nuclear/DuPont (Boston, MA). BSA was purchased from Cal- 
biochem-Behring Corp. (La Jolla, CA). 
DNA Constructs and Cell Culture 
The retroviral expression vector, preparation of virus, and the infection of 
3T3-L1 ceils have been described previously (23). Construction of the chi- 
meric transporters, the creation of a species-specific  epitope tag and the 
mutation of Leu489Leu490  were described previously (42).  The nucleo- 
tide and amino acid numberings are according to the published sequences 
of rat GLUT1 and GLUT4 (4, 6). 3T3-L1 cells were grown and differenti- 
ated  as previously described (14).  Total membranes were prepared and 
assayed for expression of chimeric transporter by Western blotting as de- 
scribed previously (23). 
Glucose Transport Assays 
3T3-L1 fibroblasts were plated in 22-ram wells of 12-well plates, induced 
to differentiate, and used between days 14-28  after differentiation. Glu- 
cose transport, as assayed by the uptake of 2-deoxy-D-[3H]glucose,  was 
measured in duplicate for the last 5 min of a 15-min insulin stimulation (fi- 
nal concentration 100 nM) as described (14). Uptake in the presence of 10 
p~M cytochalasin-B  was subtracted from all values.  Lysates were normal- 
ized  to protein concentration using the  bicinchronic acid  assay (Pierce 
Chemical Co., Rockford, IL). 
Plasma Membrane Sheet Assay 
3T3-Lt fibroblasts were plated on glass coverslips, induced to differenti- 
ate,  and used between days 14-28  after differentiation. Adipocytes were 
incubated in Leibovitz L-15 medium containing 0.2%  bovine serum albu- 
min for 2 h and then stimulated or not with insulin (final  concentration 
100 nM) for 15 min. Plasma membrane (PM) 1 "sheets" were prepared, 
fixed  and  stained  for immunofluorescence as described  previously (14, 
43). For the internalization time course, adipocytes were stimulated with 
insulin,  washed seven times with ice-cold  PBS,  and then allowed to re- 
cover for 0-180 min in Leibovitz L-15 medium containing 1.0%  BSA at 
37°C before preparation of PM  sheets. The sheets were viewed with a 
Zeiss Axiovert 135M microscope (Carl Zeiss Corp., Thornwood, NY). Im- 
ages  were  acquired  with  a  Dage-intensified  silicon-intensified-target 
(ISIT) camera (Dage Electronics, Michigan  City,  IL) and were captured 
and  analyzed  using  Image-1/Metamorph software  (Universal  Imaging 
Corp., West Chester, PA). For quantitation, the average pixel  brightness 
of at least six fields (10-20 cells/field)  was measured for each transporter at 
each time point.  In each field,  the  average pixel  brightness of the slide 
next to the cells was measured for background levels and subtracted from 
that of the cells.  The measurements at each time point  for each  trans- 
porter were then pooled to obtain means and standard errors. 
Mathematical Modeling of Glucose 
Transporter Trafficking 
The theoretical predictions of the time course of glucose transporter traf- 
ficking are based on analytical  solutions of the rate equations. The rate of 
movement of transporters out of a compartment equals the product of the 
rate constant times the amount of transporter in that compartment (first 
order kinetics)  (22). For the three-pool model, 
xp(O  =  the fraction of glucose transporters on the PM 
Xen(O  = the fraction of glucose transporters in endosomes 
xirv(t)  =  the fraction of glucose transporters in IRV 
The rate constants kendo  , kl, ks, k4, and k  z are indicated  in Fig 6. The nu- 
merical values for each rate constant are taken from published studies on 
the trafficking  of glucose transporters in 3T3-L1  adipocytes (22, 47-49). 
Rate constants with an index i represent the insulin-stimulated state. Solu- 
tion of the differential equations describing the abundance of cell surface 
glucose transporters, as well  as their steady-state distributions with and 
without hormone, will be described elsewhere (Yeh, J., Verhey, K. J., and 
Birnbaum, M. J., manuscript submitted for publication). 
The  half life  (tl/2) for recovery of subcellular distributions for each 
transporter after insulin removal is estimated experimentally by first plot- 
ting the fraction of maximal response (y) vs. time, and then applying a 
curve fit of y = m0e  mat such that tv2 =  0.693/ml.  This is an approximation 
since the real kinetics  are more complicated than a  simple exponential 
function. This estimation is expected to be somewhat smaller than mea- 
surements determined  for t~/2 by a  linear  interpolation to the  point  at 
y = 0.5. 
1. Abbreviations  used in  this paper:  IRV, insulin-responsive vesicles; PM, 
plasma membrane. 
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Subcellular Localization of the Chimeric Transporters 
As  3T3-L1  adipocytes  express  endogenous  GLUT1  and 
GLUT4, the analysis of chimeric transporters has been fa- 
cilitated by the creation of a species-specific epitope "tag" 
in the central cytoplasmic loop of the transporter  (H, Fig. 
1)  which is  recognized specifically by the  mAb G3  (43). 
Conditioned  media  containing  retrovirus  encoding  chi- 
meric transporters  were used to infect 3T3-L1 fibroblasts. 
At least 50 stable  G418-resistant clones of each construct 
were  expanded  and  screened  for expression  of chimeric 
transporter by Western blot analysis of total cellular mem- 
branes  with  mAb G3.  In addition,  each clone was tested 
for the ability to differentiate into an adipocyte-like cell, as 
assayed by the appearance of characteristic lipid droplets 
by phase contrast microscopy. Two to four clones of each 
chimeric transporter were selected for further analysis, of 
which two representative clones are shown in Fig. 2 A. The 
level of expression of chimeric transporter was quantitated 
by  Western  blotting  with  a  polyclonal  antibody  to  the 
COOH terminus of GLUT4 and was determined to be less 
than twofold that of the endogenous GLUT4 (Fig. 2 B). 
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Figure 2.  Western blot analysis of clones of 3T3-L1 cells express- 
ing the tagged chimeric transporters. (A) Total membranes from 
HeLa cells (30 txg) and from clones of 3T3-L1 fibroblasts stably 
infected  with  retrovirus  containing  the  cDNAs  encoding  the 
tagged chimeric transporters (40 o,g) were subject to SDS-poly- 
acrylamide gel electrophoresis and Western blotting with mAb 
G3 followed by 125I-protein A. (B) Total membranes from un- 
transfected  3T3-L1  adipocytes and  from adipocytes expressing 
the indicated tagged chimeric transporters (40 t~g) were subject 
to SDS-polyacrylamide gel electrophoresis and Western blotting 
with a polyclonal antibody to the COOH terminus of GLUT4 fol- 
lowed by a25I-protein A. The reactivity with ~-GLUT4 relative to 
parental 3T3-L1 adipocytes is as follows: 3T3-L1, 1.0; 4HB4 clone 
1, 1.15; 4HB4 clone 2, 1.20; 1HB4 clone 1, 1.54; 1HB4 clone 2, 
1.33. 
Figure  1.  Structures  of  chimeric  transporters.  (A)  Predicted 
transmembrane  topology of the glucose transporters.  The indi- 
cated restriction sites HindlII (D) and BgllI (B) were utilized to 
exchange portions of the GLUT1 and GLUT4 cDNAs. H desig- 
nates  the  amino acid of GLUT1  altered  to create  the  human 
epitope tag. LL indicates the LeuLeu residues that were altered 
to AlaSer in the COOH terminus of GLUT4. (B) Contribution of 
GLUT1 (light gray bars) and GLUT4 (dark gray bars) sequences 
to each chimeric transporter. For the naming of the chimeras, the 
numbers refer to the contribution of GLUT1 or GLUT4 at the 
NH2 and COOH termini, H  designates the human epitope tag, 
and B refers to the BgllI site.  (C) The primary amino acid se- 
quence of GLUT4 following the BgllI site. The leucine residues 
that were mutated are indicated. MS, membrane spanning. 
The subcellular localization of the chimeric transporters 
in 3T3-L1 fibroblasts, determined by indirect immunofluo- 
rescence microscopy with mAb G3 (Fig. 3), was similar to 
that in NIH3T3 fibroblasts (42, 43). The transporter 1HB1 
displayed the characteristic cell surface staining of GLUT1 
in fibroblasts  whereas  4HB4 was localized to the perinu- 
clear region of the cell, identical  to the  localization seen 
for  GLUT4  (23,  43).  The  chimeric  transporter  4HB1, 
which contains the NH2-terminal 183 amino acids of GLUT4, 
showed some predominant staining of the perinuclear re- 
gion, though there was sometimes slight staining of the pe- 
riphery of the cell. The chimera 1HB4, which contains the 
COOH-terminal 30 amino acids of GLUT4, was localized 
to the perinuclear region of the cell in a  pattern indistin- 
guishable  from 4HB4  and  GLUT4.  The  mutation  of the 
dileucine  motif within the GLUT4 COOH terminus,  chi- 
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transporters  in 3T3-L1 fibroblasts. Clones of 3T3-L1 fibroblasts 
stably expressing the  tagged chimeric transporters  were  fixed, 
permeabilized, and stained with mAb G3 and rhodamine-conju- 
gated goat anti-mouse secondary antibody. Bar, 20/xm. 
meras  1HB4(LL489AS) and  4HB4(LL489AS), caused  a 
redistribution of the transporter from the perinuclear re- 
gion to the periphery of the cell, consistent with increased 
expression on the plasma membrane. 
To  identify  sequences  responsible  for  the  subcellular 
sorting of GLUT4 in its physiologically relevant cell type, 
the clones expressing chimeric transporters were plated on 
coverslips, induced to differentiate into adipocytes and the 
subcellular location of the transporters in the basal and in- 
sulin-stimulated states determined by the PM sheet assay 
(Fig. 4). Since all cell lines express approximately the same 
level of total heterologous transporter (Fig. 2 A), the abso- 
lute amount of chimera on the cell surface also represents 
its fractional distribution to this compartment. The trans- 
porter  1HB1  is present  on the plasma membrane in the 
basal state and increases upon stimulation of the cells by 
insulin  (Fig.  4 A), consistent with the known behavior of 
endogenous, wild-type GLUT1 (8). Note that immunoflu- 
orescence using the anti-GLUT4 antisera in the 1HB1 cell 
line indicates the distribution of the endogenous GLUT4 
with and without exposure of cells  to hormone. No stain- 
ing of the PM sheets by mAb G3 can be seen for 4HB4 in 
the  basal  state;  however  there  is  intense  staining  upon 
stimulation of the cells  with insulin similar to the staining 
pattern  of endogenous GLUT4 in the basal and insulin- 
stimulated  states  (Fig.  4  A).  The  chimera  4HB1  shows 
minimal localization to the PM in the basal state; stimula- 
tion of these cells by insulin causes a slight increase in this 
staining (Fig.  4 B). There is no staining of PM sheets by 
mAb G3 from cells expressing 1HB4 in the absence of in- 
sulin,  though stimulation by insulin  causes redistribution 
of this chimeric transporter to the cell surface (Fig.  4 B), 
similar  to  that for 4HB4  and  GLUT4 (Fig.  4 A).  These 
data suggest that the NH2 terminus of GLUT4 contains in- 
formation capable of localizing the transporter to the inte- 
rior of the cell,  although not to a maximally insulin-sensi- 
tive compartment. These data also suggest that the COOH 
terminus of GLUT4 contains information sufficient to tar- 
get  the  transporter  to  an  intracellular  storage  site  from 
which it is recruited to the plasma membrane in response 
to insulin. 
The  dileucine  motif  within  the  COOH  terminus  of 
GLUT4 is necessary for its intracellular  sequestration in 
NIH3T3 and 3T3-L1 fibroblasts (above; reference 42). Upon 
Figure 4.  Localization of the tagged chimeric transporters in 3T3- 
L1 adipocytes in the basal and insulin-stimulated states by label- 
ing of PM sheets. Clones of 3T3-L1 adipocytes stably expressing 
the tagged chimeric transporters  1HB1 and 4HB4 (A), 1HB4 and 
4HB1 (B), and 1HB4(LL489AS) and 4HB4(LL489AS) (C) were 
stimulated or not with insulin (100 nM, 15 min) and then sonified 
to prepare  PM sheets. These were fixed and labeled with mAb 
G3 and a rabbit polyclonal antibody to the COOH terminus of 
GLUT4,  and  followed  by  rhodamine-conjugated  goat  anti- 
mouse secondary antibody and FITC-conjugated goat anti-rabbit 
secondary antibody, respectively. Bar, 20 I~m. 
differentiation of these cells to adipocytes, however, the mu- 
tant transporters 1HB4(LL489AS) and 4HB4(LL489AS) no 
longer were detected at the PM by mAb G3 in the basal 
state (Fig.  4 C). Not only are the mutant transporters ab- 
sent from the cell surface, but they are sequestered inside 
the cell in a storage compartment capable of insulin-stimu- 
lated  translocation  to  the  plasma  membrane  to  a  level 
comparable to 4HB4 (Fig. 4 C). 
Adipocytes Expressing the Chimeric Transporters 
Accumulate Hexose at Increased Rates 
Two criteria  have been  used  historically to demonstrate 
the validity of 3T3-L1 adipocytes as an authentic insulin- 
responsive  cell  line:  insulin-stimulated  translocation  of 
GLUT4 to the cell  surface (shown in these studies by the 
PM sheet assay) and a rapid increase in the rate of hexose 
uptake (8, 32). Subcloning of 3T3-L1 cells often results in 
subpopulations which have quite variable rates of hexose 
uptake, particularly after exposure to insulin (17).  In this 
study,  selection of G418-resistant  clones on the  basis  of 
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prove the ability of insulin to activate hexose uptake (Ta- 
ble I). However, despite clonal differences, the data shown 
in Table I  are consistent with the PM sheet assay. Insulin 
stimulated  hexose uptake almost 10-fold in untransfected 
3T3-L1  adipocytes.  Adipocytes  expressing  the  chimeric 
transporter  1HB1 displayed elevated  levels of both basal 
and insulin-stimulated  hexose uptake compared to paren- 
tal cells, as reported previously for GLUT1  (19). This re- 
sulted in a  lower-fold stimulation and presumably reflects 
the cell surface localization of this transporter in the basal 
state.  Expression  of the  chimeric  transporter  4HB1  re- 
sulted in basal and insulin-stimulated  levels of hexose up- 
take  similar  to those  of untransfected  adipocytes.  This  is 
consistent with both the primarily intracellular localization 
of this transporter in the basal state  and its minimal insu- 
lin-stimulated translocation to the cell surface. Adipocytes 
expressing  the  chimeric  transporters  4HB4,  1HB4,  or 
1HB4(LL489AS) showed levels of basal transport compa- 
rable to parental cells; however, a larger degree of insulin- 
stimulated  transport than in the untransfected  adipocytes 
was observed,  resulting  in  a  larger  fold stimulation.  This 
most likely corresponds to the increased level of "GLUT4" 
in  these  cells  as  seen  by staining  PM  sheets  of cells  ex- 
pressing these chimeras in the insulin-stimulated state. 
The Effect of the Dileucine Motif in the COOH 
Terminus of GLUT4 
A  dileucine motif has been suggested as comprising a criti- 
cal part  of the  sorting  signals  of several  membrane  pro- 
teins,  and  has been implicated  in sorting from the TGN, 
the  PM  and  endosomes  (for  review  see  reference  33). 
Since mutation of the dileucine motif in the COOH termi- 
nus of GLUT4 did not affect its correct localization to an 
insulin-sensitive storage compartment in adipocytes (above), 
we sought to determine whether this motif was instead af- 
fecting  the  sorting  of  the  transporters  at  the  PM  after 
translocating in response to insulin. Adipocytes expressing 
the chimeric transporters  were stimulated,  washed exten- 
sively at 4°C to remove insulin,  and allowed to recover at 
37°C for the  times  indicated  in  Fig.  5  before  PM  sheets 
were prepared. PM sheets of untransfected 3T3-L1 adipo- 
cytes showed staining for the endogenous GLUT1  in the 
basal state, increased staining in response to insulin, and a 
rapid re-equilibration to basal levels upon insulin removal 
(Fig. 5 A). Virtually identical results were obtained when 
staining for the chimeric transporter  1HB1 with mAb G3 
Table I. 2-deoxy-Glucose Uptake (pmol/mg/min  ) 
Cell line  -Insulin  + Insulin  Fold stimulation 
3T3L1  42.1 (± 3.0)  329.1  (±  10.5)  7.8 
1HB1  108.7 (± 24.9)  379.7 (-  21.9)  3.5 
4HB4  27.4 (± 4.9)  442.1  (+ 69.7)  16.2 
4HB1  59.6 (-  15.4)  421.9 (± 20.8)  7.1 
1HB4  30.5 (± 4.3)  597.7 (± 56.1)  19.6 
1HB4(LL489AS)  38.7 (± 5.3)  482.9 (± 5.8)  12.5 
Untransfected  3T3-L1  adipocytes and clones of 3T3-LI adipocytes stably expressing 
the tagged chimeras were stimulated or not with insulin (100 nM,  15 rain) and hexose 
uptake was measured in duplicate for the last 5 min. Hexose uptake for each clone 
was determined in one to four experiments, and the data from the clones of each chi- 
mera were pooled (three to six total samples/chimera). Values are expressed as the 
mean (_+ SEM). 
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Figure 5.  Time  course  of the  cell  surface  localization  of the 
tagged chimeric transporters after the removal of insulin by label- 
ing  of PM  sheets.  Untransfected  3T3-L1  adipocytes  (A)  and 
clones of 3T3-L1  adipocytes stably expressing the tagged chime- 
ras 1HB1 and 4HB4 (B), or 4HB1, 1HB4, and 1HB4(LL489AS) 
(C) were stimulated or not with insulin  (100 nM,  15 min).  The 
cover slips were washed with ice-cold PBS to remove insulin  and 
then returned to 37°C for 0, 15, 30, or 60 min before PM sheets 
were prepared and stained with a polyclonal antibody to GLUT1 
or  GLUT4  (A)  or  with  mAb  G3  (B  and  C)  followed  by 
rhodamine-conjugated  secondary  antibodies.  (D)  Fluorescent 
staining of PM sheets was quantitated using Imagel/Metamorph 
image processing software. Data are presented as the percent of 
change in PM staining due to insulin for each chimera, and repre- 
sent the mean (- SEM) of six fields (10-20 cells/field). Bar, 20 Ixm. 
(Fig. 5 B). PM sheets of untransfected  adipocytes showed 
no staining  for endogenous  GLUT4 in  the  basal  state,  a 
large  increase  upon  insulin  stimulation,  and  a  rapid  de- 
crease after the removal of insulin, such that the GLUT4 
staining returned to basal levels within 30 min (Fig. 5 A). 
This  corresponds  to  the  rapid  decrease  in  cell  surface 
GLUT4 and glucose uptake  after removal of insulin  (34, 
Verhey et al. Glucose Transport Targeting Signals  1075 47). Virtually identical results were found for the chimeric 
transporters 4HB4 and 1HB4 as ascertained with mAb G3 
(Fig. 5, B and C, respectively). The relatively small amount 
of transporter  4HB1  which  redistributed  to the  cell  sur- 
face, though difficult to measure precisely, appeared to be 
rapidly removed upon washing  away insulin  (Fig. 5  C). 
The mutant transporter 1HB4(LL489AS) showed staining 
patterns similar to those of 1HB4 in the basal and insulin- 
stimulated  states;  however,  the  abundance  of  1HB4 
(LL489AS) on the PM sheets decreased quite slowly after 
the removal of insulin  (Fig. 5  C). The  transporter  1HB4 
(LIA89AS) was undetectable  on PM sheets 3 h  after the 
removal of insulin (Fig. 5 D; and data not shown). 
Prediction of Glucose Transporter Distributions by 
Computer Simulation 
Computer simulation of GLUT4 trafficking using the rate 
constants shown in Fig. 6 predicts that GLUT4 changes in 
abundance at the cell surface from 0.9 to 41.1% after insu- 
lin stimulation and is internalized with a tl/2 =  5 min after 
insulin removal (Fig. 6). These values are similar to the re- 
ported  data for GLUT4 trafficking in 3T3-L1  adipocytes 
and  are  consistent  with  the  distribution  of  GLUT4  in 
brown adipose tissue as visualized by electron microscopy 
(36, 37, 47, 49). 4HB4 displays a significant movement to 
the  cell  surface  after  exposure  of cells  to insulin,  and  a 
measured  tl/2 of reinternalization following hormone with- 
drawal  of 3.8 min  (Figs.  5  and  6).  A  similar  analysis  for 
GLUT1 and 1HB1 indicates that the behavior of heterolo- 
gous,  epitope-tagged  chimeric  transporters  is  indistin- 
guishable from that reported for the corresponding endog- 
enous wild-type carriers and closely matches the predicted 
values  (compare Figs. 4  and 5  to the predicted  values in 
Fig. 6). 
Fig. 6, B  and E  show the predicted tl/2 for steady-state 
subcellular distributions and reinternalization,  respectively, 
for the chimeric transporters  based on assignment  of the 
information  encoding  targeting  to  the  insulin-responsive 
vesicles (IRV) (ks) exclusively to the COOH terminus of 
GLUT4. As can be seen, the experimental data match the 
calculated  values  within  the  limits  of measurement.  The 
small amount of 4HB1  at the PM under basal conditions 
predicted  by the model is barely detectable  by the  sheet 
assay, and therefore  the tl/2 after insulin  removal is diffi- 
cult  to  measure.  The  effect  of LeuLeu  residues  in  the 
COOH  terminus  of GLUT4,  shown  to be important  for 
the correct intracellular sequestration of the transporter in 
fibroblasts  (10,  42),  is  shown  in  Fig.  7.  Dileucine  motifs 
have  been  implicated  in  sorting  of membrane  proteins 
from the PM to endosomes as well as from the trans-Golgi 
network to endosomes (33). Fig. 7 A  shows the predicted 
distributions  of the  transporters  if  mutation  of LeuLeu 
were to affect their trafficking between the PM and endo- 
somes, but not change k5 or k4. We have performed com- 
puter simulation of mutant transporter  trafficking assum- 
ing  that  alteration  of  the  dileucine  motif  affects  the 
distribution of transporter by either decreasing k~ndo or by 
increasing k~ (Fig. 7). Either mechanism predicts retention 
of the mutant transporter in the basal state and significant 
translocation in response to insulin, as we have found ex- 
perimentally  (Fig.  4  C).  However,  modeling an effect of 
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time (minutes) 
Figure 6.  Model for the subcellular trafficking of glucose trans- 
porters in adipocytes. (A) Three-pool model for transporter traf- 
ficking, k,,do, rate of endocytosis, k/, rate of recycling to the cell 
surface, k,, rate of sequestration in IRV. k4, rate of recycling to 
endosomes. ENDO, endosomes. IRV, insulin-responsive vesicles. 
(B) Assigned rate constants for transporter trafficking and pre- 
dicted  subcellular  distributions  of chimeric transporters  in  the 
basal and insulin-stimulated states.  (C) Computer simulation of 
transporters remaining at the cell surface after the removal of in- 
sulin. (D) pred., each predicted tv2 was calculated as described in 
the Methods using the constants, meas., the measured tx~2 were 
determined from the data in D. N.D., not determined. The level 
of 4HB1 present in the PM sheets in insulin-stimulated  state  is 
too low to permit calculation of kinetic parameters for the traf- 
ficking of this chimeric transporter. 
the LL489AS mutation on  kendo predicts a marked inhibi- 
tion in the rate of internalization of chimera from the cell 
surface following withdrawal of insulin, consistent with the 
experimental data (Fig. 6 D). 
Discussion 
The  expression  of  GLUT1  and  GLUT4  in  several  cell 
types has  demonstrated  that,  in spite  of 65%  identity  in 
amino  acid  sequence,  each isoform possesses  distinct  in- 
formation conferring subcellular targeting (18, 23, 28, 35). 
Experimental  strategies based on the construction of chi- 
meric  transporter  proteins  have  led  to  identification  of 
several structural domains implicated as critical to the in- 
tracellular  sequestration  of GLUT4  (11,  27,  29,  30,  43). 
However,  a  major limitation  of the  previous  studies  has 
been  that  none  of the  cells  into  which  the  transporters 
have been introduced represents  a  physiologically mean- 
ingful model system as defined by two criteria: expression 
of significant  quantities  of the  endogenous  GLUT4 glu- 
cose transporter and an insulin-stimulatable  augmentation 
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Figure  7.  Model  for  the  subcellular  trafficking  of  1HB4  and 
1HB4(LL489AS)  in adipocytes.  (A) Assigned rate constants  and 
resultant subcellular  distributions  of the transporters in the basal 
and inulin-stimulated  states if the dileucine  mutation affects ei- 
ther kendo or k~. BAS, basal. INS, insulin. (B) Computer simula- 
tion of transporters remaining at the cell surface after insulin re- 
moval  if  the  dileucine  mutation  affects  kendo. (C)  Computer 
simulation of transporters remaining at the cell surface after insu- 
lin removal if the dileucine mutation affects ka. 
in hexose uptake comparable to the in vivo target tissue. 
Numerous published studies have affirmed the validity of 
the 3T3-L1 adipocyte as a model for hormone-responsive 
fat cells (8, 15, 32). The development of the differentiated 
phenotype may well be accompanied by the accumulation 
of adipocyte-specific proteins which specifically associate 
with GLUT4 and participate in either its sorting to an hor- 
mone-regulatable intracellular  storage vesicle or insulin- 
dependent translocation to the plasma membrane. Consis- 
tent with these ideas, we have found our own data on the 
steady-state distributions  of recombinant  transporters  in 
NIH-3T3 fibroblasts to be either predictive of the behav- 
ior of chimerae  in  adipocytes, or misleading,  depending 
upon  the  signal.  Thus,  the  present  study  has  confirmed 
that the COOH-terminal 30 amino acids of GLUT4, iden- 
tified as important for subcellular sorting by expression of 
chimeric transporters in undifferentiated cell types (11, 27, 
43), are also critical for trafficking in adipocytes. However, 
the  dileucine  motif contained  within  this  region  of the 
transporter which is crucial for intracellular sequestration 
in fibroblasts (10, 42),  was not required  for hormone re- 
sponsiveness in adipocytes, although it may contribute to 
the rate at which GLUT4 returns to the cell interior after 
withdrawal of insulin. 
A  major obstacle to determining the  basal subcellular 
localizations of GLUT1 and GLUT4, as well as their redis- 
tributions in response to insulin, has been the difficulty in 
obtaining  pure  membrane  fractions  from cultured  cells. 
Classical  cell  fractionation  seriously  underestimates  the 
recruitment of GLUT4 to the plasma membrane, almost 
certainly due to contamination of the PM with intracellu- 
lar membranes (8, 19, 45). The use of immunoelectron mi- 
croscopy,  while  allowing  the  demonstration  of  marked 
insulin-dependent GLUT4 translocation, has also been as- 
sociated with misleading results due to non-specific label- 
ing and epitope-masking anomalies (37, 38, 44). The use of 
the cell-impermeant photolabel ATB-BMPA (2-N-4-[1-azi- 
2,2,2-trifluoroethyl]benzoyl-l,3-bis(D-mannos-4-yloxy)-2- 
propylamine) has contributed significant information about 
trafficking of transporters, but has been criticized for po- 
tential artifacts related to its binding only to catalytically 
active  transporters  (12,  22).  In  these  studies,  we  have 
elected to utilize the PM sheet assay to directly ascertain 
the abundance of transporters at the cell surface (14, 20, 
30,  31,  43).  Since  cell  lines  were  selected  for  relatively 
equivalent  levels  of  expression  of  heterologous  trans- 
porter, measurement of surface transporter allows extrap- 
olation of the fractional distribution of a given chimera be- 
tween the plasma and intracellular membranes. Robinson 
et al. (31)  have clearly demonstrated that PM sheets are 
essentially devoid of intracellular organelles, and we have 
found that the abundance of GLUT4 on the attached sur- 
face  of  the  adipocyte  reflects  an  equivalent  density  of 
transporter  on the  apical plasma membrane  (Hausdorff, 
S.F.,  and  M.  J.  Birnbaum,  unpublished  observations). 
Quantitation  of the PM sheet assay leads to a magnitude 
of insulin-stimulated GLUT4 translocation comparable to 
that found by immunoelectron microscopy in  white  adi- 
pose  tissue  and  ATB-BMPA  labeling  in  3T3-L1  adipo- 
cytes (8, 31, 38). Thus we believe that the subcellular local- 
izations  of GLUT1  and  GLUT4 as  assessed by the  PM 
sheet assay are an accurate reflection of the processes oc- 
curring in the intact adipocyte, with the reservation that it 
is difficult to quantitate  low levels of transporter on the 
cell surface. The most compelling argument in support of 
the  validity of this  assay is the  congruence  between  our 
data and that obtained with other techniques studying en- 
dogenous, wild-type glucose transporters (see below). 
As has been postulated in the past, we favor a model in 
which  GLUT1  and  GLUT4 are distributed  among three 
compartments in adipocytes: the plasma membrane, a non- 
specialized endosomal compartment, and  insulin-respon- 
sive vesicles (Fig. 6 A) (5, 22). In the basal state, there is an 
isoform-specific bias in the distribution of transporter be- 
tween endosomes and the two other communicating com- 
partments. GLUT4 has a greater tendency than GLUT1 to 
remain in endosomes as opposed to the cell surface. Based 
on the data presented in this communication, we suggest 
that this propensity is conferred by information in both the 
NH2 and COOH termini of the GLUT4 protein. In addi- 
tion,  GLUT1  is  virtually  excluded  from  IRV  whereas 
GLUT4 is  rapidly  and  efficiently sorted  to  this  storage 
pool. The signal dictating targeting to IRV is encoded ex- 
clusively by a dileucine-independent signal in the COOH- 
terminal 30 amino acids. 
Chimeric transporters fusing the NH  2 terminus of GLUT4 
to the COOH-terminus of GLUT1 have been reported to 
localize to the interior of CHO fibroblasts (30). A phenyl- 
alanine  residue  within  this region has been suggested to 
function in the internalization of transporters from the cell 
surface  (16,  29).  The  chimeric transporter  4HB1,  which 
contains  the  NH2-terminal  183  amino  acids  of GLUT4, 
also showed some intracellular localization in NIH3T3 and 
3T3-L1 fibroblasts (43; and Fig. 3), though other investiga- 
tors have found this chimeric transporter located primarily 
at the cell surface in COS cells and Xenopus oocytes (11, 
27). In 3T3-L1 adipocytes, the chimeric transporter 4HB1 
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the basal state, and only slightly redistributed  to the cell 
surface in response to insulin (Figs. 4 and 5). We interpret 
this as indicating that the amino terminus contributes suf- 
ficient information to allow removal of transporters from 
the cell surface, but not sorting to the insulin-responsive 
compartment. The simplest explanation is that 4HB1  re- 
sides  in  endosomes  in  the  basal  state  and  undergoes  a 
modest translocation in response to insulin. 
As in several studies involving fibroblasts, the COOH- 
terminal 30 amino acids of GLUT4 was sufficient to dic- 
tate intracellular sequestration of chimeric transporters in 
3T3-L1 fibroblasts and adipocytes (11,  27, 43) (Fig. 4). In 
the fat cell,  1HB4 shows insulin-stimulatable recruitment 
to the cell surface comparable to both wild-type endoge- 
nous GLUT4 and 4HB4 (Figs. 4 and 5), suggesting that the 
COOH terminus of GLUT4 contains the necessary infor- 
mation to target the transporter to the IRV. The LeuLeu 
residues within this region have been shown to be impor- 
tant for efficient intracellular sequestration  of the trans- 
porter in  fibroblasts  (10,  42).  In  adipocytes, the  mutant 
transporters  4HB4(LIA89AS)  and  1HB4(LIA89AS)  are 
intracellular in the basal state and move to the cell surface 
upon stimulation of the cells by insulin  (Fig. 4); we con- 
sider this evidence of their localization in IRV in the basal 
state. After removal of insulin, these mutants are reinter- 
nalized slower than the comparable chimera with an intact 
dileucine, indicating that this motif does have some role in 
sorting in adipocytes (Fig.  5).  A  plausible explanation is 
that the LeuLeu-based motif has a role analogous to the 
NH2-terminal signal in favoring distribution of GLUT4 in 
endosomes as opposed to the plasma membrane. In any 
case, these data clearly show that sequences in the COOH 
terminus of GLUT4 distinct from the dileucine motif are 
involved in sorting to the IRV. 
To test our model of glucose transporter trafficking and 
the sorting signals we postulate, we referred to the exten- 
sive  mathematical  analysis  by  Holman  and  coworkers 
based  on  their  studies  with  the  membrane-impermeant 
photoaffinity reagent ATB-BMPA (22).  Our results with 
chimeric transporters support their conclusion excluding a 
single  intracellular  pool  of  transporters;  instead,  there 
must be at least two pools of transporters inside the cell, 
distinguishable by their capacities to respond to insulin by 
translocating  to  the  cell  surface.  Our  model,  which  is 
shown in Fig. 6, was developed with the following consid- 
erations.  First, we have assigned rate constants for wild- 
type  transporter  trafficking  based  on  experiments  per- 
formed in 3T3-L1 adipocytes (47, 49). Second, Holman et 
al. (22), who only considered the trafficking of GLUT4, as- 
sumed a  non-reversible movement of transporter among 
the three pools and set the rate constants kl and k4 equal 
to 0; however, since GLUT1 is likely to move from endo- 
somes directly to the cell surface, we set kl  =  0.04. Third, 
since  several  studies  have  indicated  that  GLUT1  and 
GLUT4 have identical rates of endocytosis, kendo  =  0.12 
for all transporters in the basal state (47, 49).  Insulin has 
been reported to decrease kendo, so we set kendo =  0.08 in 
the insulin-stimulated  state,  similar to the 30%  decrease 
measured in 3T3-L1 adipocytes (49). Fourth, insulin stim- 
ulation affects the translocation of proteins from both in- 
tracellular pools to the cell surface, although not equally. 
Thus,  the  rate  of translocation from endosomes  (kl)  in- 
creases threefold upon insulin stimulation, consistent with 
the behavior of GLUT1 in adipocytes and GLUT4 in fi- 
broblasts, whereas the rate of translocation from insulin- 
responsive vesicles (k2) increases 100-fold (22, 25). 
All rates of chimeric and mutant transporter trafficking 
we  have  measured  in  these  experiments  are  consistent 
with a three-pool model with targeting dictated by the fol- 
lowing sorting signals: (a) a decreased cycling of GLUT4 
compared  to  GLUT1  from  endosomes  to  the  plasma 
membrane, due  to information residing in  the  two cyto- 
plasmic ends  of the  former transporter,  (b)  a  dileucine- 
independent  signal  in  the  COOH  terminus  of  GLUT4 
governing targeting to IRV; and (c) the effect of ablation 
of the  dileucine  leading  to  a  decrease  in  the  rate of en- 
docytosis of the mutant transporter. Thus, the virtual ex- 
clusion of GLUT4 from the cell surface in the basal state is 
due  to  two factors:  retention  in  endosomes and  specific 
sorting to IRV. In the non-insulin-responsive cells investi- 
gated previously, it is likely that only the first mechanism 
is operative, that is, the IRV and sorting of proteins to it 
are adipocyte specific. 
One final caveat should be stated. We have referred to 
IRV as a  specialized compartment, the implication being 
the existence of a  distinct organelle. However, a  mecha- 
nism by which  GLUT4 is specifically sequestered  within 
the endosome, and then escorted to the cell surface in re- 
sponse to insulin,  would  be consistent with the data and 
hypotheses presented in this report. 
The authors gratefully acknowledge the assistance of Drs. Sharon Haus- 
dorff and Le Ma in quantitating images, and Cass Lutz in preparing the 
manuscript. 
This  work  was  supported  by  National  Institutes  of  Health  grant 
DK39519 to M. J. Birnbaum. 
Received for  publication 17  March  1995  and  in  revised form  28  April 
1995. 
References 
1.  Amigorena, S., J. R. Drake, P. Webster, and I. Mellman. 1994. Transient 
accumulation of new class ii mhc molecules in a novel endocytic compart- 
ment in b lymphocytes. Nature (Lond.). 369:113-120. 
2. Baldini, G., T. Hohl, H. Y. Lin, and H. F. Lodish. 1992. Cloning of a Rab3 
isotype predominantly expressed in adipocytes. Proc.  Natl.  Acad.  Sci. 
USA. 89:5049-5052. 
3.  Baldini, G., R. Hohman, M. J. Charron, and H. F. Lodish. 1991. Insulin and 
nonhydrolyzable GTP  analogs induce translocation of GLUT 4  to the 
plasma membrane in alpha-toxin-permeabilized rat adipose cells. J. Biol. 
Chem. 266:40374040. 
4.  Birnbaum, M. J. 1989. Identification of a novel gene encoding an insulin- 
responsive glucose transporter protein. Cell. 57:305--315. 
5.  Birnbaum, M. J. 1992. The insulin-responsive glucose transporter. Int. Rev. 
Cytol. 137A:239-297. 
6.  Birnbaum, M. J., H. C. Haspel, and O. M. Rosen. 1986. Cloning and charac- 
terization of a cDNA encoding the rat brain glucose-transporter protein. 
Proc. Natl. Acad. Sci  USA. 83:5784-5788. 
7.  Cain, C.  C.,  W.  S. Trimble, and G.  E. Lienhard.  1992.  Members of the 
VAMP  family of synaptic vesicle proteins are components of glucose 
transporter-containing vesicles from rat adipocytes. J.  Biol.  Chem.  267: 
11681-11684. 
8.  Calderhead, D. M., K. Kitagawa, L. I. Tanner, G. D. Holman, and G. E. 
Lienbard. 1990. Insulin regulation of the two glucose transporters in 3T3- 
L1 adipocytes. J. Biol. Chem. 265:13801-13808. 
9.  Clark, A. E., G. D. Holman, and I. J. Kozka. 1991. Biochem J. 278:235-241. 
10.  Corvera, S.,  A.  Chawla, R.  Chakrabarti, M.  Joly, J.  Buxton,  and  M.  P. 
Czech.  1994.  A  double leucine within the GLUT4  glucose transporter 
COOH-terminal domain functions as an endocytosis signal. J.  Cell Biol. 
126:979-989. 
11. Czech, M. P., A. Chawla, C.-W. Woon, J. Buxton, M. Armoni, T. Wei, M. 
Joly, and S. Corvera. 1993. Exofacial epitope-tagged glucose transporter 
chimeras reveal COOH-terminal sequences governing cellular localiza- 
The Journal of Cell Biology, Volume 130,  1995  1078 tion. Z  Cell Biol. 123:127-136. 
12. Czech, M. P., B. M. Clancy, A. Pessino, C.-W. Woon, and S. Harrison. 1992. 
Complex regulation of simple sugar transport in insulin-responsive cells. 
Trends Bioehem. Sci. 17:197-201. 
13. Deen, P. M., M. A. Verdijk, N. V. Knoers, B. Wieringa, L. A. Monnens, 
C. H. van Os, and B. A. van Oost. 1994. Requirement of human renal wa- 
ter  channel  aquaporin-2  for  vasopressin-dependent  concentration  of 
urine. Science (Wash. DC). 264:91-95. 
14. Fingar, D. C., S. F. Hausdorff, J. Blenis, and M. J. Birnbaum. 1993. Dissoci- 
ation of pp70 ribosomal protein $6 kinase from insulin-stimulated glu- 
cose transport in 3T3-L1 adipocytes. J. BioL Chem. 268:3005-3008. 
15. Garcia de Herreros, A, and M. J. Birnbaum. 1989. The acquisition of in- 
creased insulin-responsive glucose transport in 3T3-LI adipocytes corre- 
lates with expression of a  novel transporter gene. J.  Biol.  Chem.  264: 
19994-19999. 
16.  Garippa, R. J., T. W. Judge, D. E. James, and T. E. McGraw. 1994. The 
amino terminus of GLUT4 functions as an internalization motif but not 
an intracellular retention signal when substituted for the transferrin re- 
ceptor cytoplasmic domain. J. Cell Biol. 124:705--715. 
17.  Gould, G. W., V. Derechin, D. E. James, K. Tordjman, S. Ahem, E. M. 
Gibbs, G. E. Lienhard, and M. Mueckler, 1989. Insulin-stimulated trans- 
location of the HepG2/erythrocyte-type glucose transporter expressed in 
3T3-LI adipocytes. J. Biol. Chem. 264:2180-2184. 
18. Haney, P. M., J. W. Slot, R. C. Piper, D. E. James, and M. Mueckler. 1991. 
IntraceUular  targeting  of  the  insulin-regulatable glucose  transporter 
(GLUT4) is isoform specific and independent of cell type. J.  Cell Biol. 
114:689-699. 
19. Harrison, S. A., J. M. Buxtou, B. M. Clancy, and M. P. Czech. 1990. Insulin 
regulation of hexose transport in mouse 3T3-L1 cells expressing the hu- 
man HepG2 glucose transporter. J. Biol. Chem. 265:20106-20116. 
20.  Hausdorff, S. F., J. V. Frangioni, and M. J. Birnbaum. 1994. Role of p21  ras 
in  insulin-stimulated glucose transport  in  3T3-L1  adipocytes. J.  Biol. 
Chem. 269:21931-21934. 
21. Holman, G. D., I. J. Kozka, A. E. Clark, C. J. Flower, J. Saltis, A. D. Hab- 
berfield, I. A. Simpson, and S. W. Cushman. 1990. Cell surface labeling  of 
glucose transporter isoform GLUT4 by bis-mannose photolabel. Correla- 
tion with stimulation of glucose transport in rat adipose ceils by insulin 
and phorbol ester. J. Biol. Chem. 265:18172-18179. 
22. Holman, G. D., L. L. Leggio, and S. W. Cushman. 1994. Insulin-stimulated 
GLUT4 glucose transporter recycling.  J. Biol. Chem. 269:17516-17524. 
23.  Hudson, A. W., M. L. Ruiz, and M. J. Birnbaum.  1992.  Isoform-specific 
subcellular targeting of glucose transporters in mouse fibroblasts. J.  Cell 
Biol. 116:785-797. 
24.  Jhun, B. H., A. L. Rampal, H. Liu, M. Lachaal, and C. Y. Jung. 1992. Evi- 
dence of constitutive GLUT4 recycling.  J, Biol. Chem, 267:17710-17715. 
25. Kanai,  F.,  Y.  Nishioka, H.  Hayashi,  S.  Kamohara,  M.  Todaka,  and  Y. 
Ebina. 1993. Direct demonstration of insulin-induced GLUT4 transloca- 
lion to the surface of intact cells by insertion of a c-myc epitope into an 
exofacial GLUT4 domain. J. Biol. Chem. 268:14523-14526. 
26.  Laurie, S.  M.,  C.  C.  Cain, G,  E.  Lienhard, and J.  D,  Castle.  1993. The 
glucose  transporter  GIuT4  and  secretory  carrier  membrane  proteins 
(SCAMPs) colocalize in rat adipocytes and partially segregate during in- 
sulin stimulation. J. Biol. Chem, 268:19110-19117. 
27. Marshall, B., H. Murata, R. Hresko, and M. Mueckler. 1993. Domains that 
confer intracellular sequestration of the Glut4 glucose transporter in Xe- 
nopus oocytes. J. Biol. Chem. 268:193-199. 
28. Piper, R. C., L. J. Hess, and D. E. James. 1991. Differential sorting of two 
glucose transporters expressed in insulin-sensitive cells. Am. J. Physiol. 
260:C570-580. 
29.  Piper, R. C., C. Tai, P. Kulesza, S. Pang, D. Warnock, J. Baenziger, J. W. 
Slot, H. J, Geuze, C. Puri, and D. E. James. 1993. GLUT-4 NH2 terminus 
contains a phenylalanine-based targeting motif that regulates intracellu- 
lar sequestration. J. Cell Biol. 121:1221-1232. 
30.  Piper, R. C, C. Tai, J. W. Slot, C. S. Hahn, C. M. Rice, H. Huang, and D. E. 
James. 1992. The efficient intracellular sequestration of the insulin-regu- 
latable glucose transporter (GLUT-4) is conferred by the NH2 terminus. 
J. Cell Biol. 117:729-743. 
31.  Robinson, L. J., S. Pang, D. S. Harris, J. Heuser, and D. E. James. 1992. 
Translocation of the glucose transporter (GLUT4) to the cell surface in 
permeabilized 3T3-L1  adipocytes: effects of ATP, insulin, and GTPgS 
and localization of GLUT4  to clathrin lattices. J.  Cell Biol.  117:1181- 
1196. 
32.  Rubin, C. S., A, Hirsch, C. Fung, and O. M. Rosen. 1978. Development of 
hormone receptors and hormonal responsiveness in vitro. J. Biol. Chem. 
253:7570-7578. 
33.  Sandoval, I. V., and O. Bakke. 1994. Targeting of membrane proteins to 
eudosomes and lysosomes. Trends Cell Biol. 4:292-297. 
34.  Satoh, S., H. Nishimura, A. E. Clark, I. J. Kozka, S. J. Vannucci, I. A. Simp- 
son, M. J. Quon, S. W. Cushman, and G. D. Holman. 1993. Use of bis- 
mannose photolabel to elucidate insulin-regulated GLUT4  subcellular 
trafficking kinetics in rat adipose cells. Evidence that exocytosis is a criti- 
cal site of hormone action. J. BioL Chem. 268:17820-17829. 
35.  Shibasaki, Y., T. Asano, J.-L. Lin, K. Tsukuda, H. Katagiri, H. Ishihara, Y. 
Yazaki, and Y. Oka. 1992. Two glucose transporter isoforms are sorted 
differentially and are expressed in distinct cellular compartments. Bio- 
chem. J. 281:829-834. 
36. Slot, J. W., H. J. Geuze, S. Gigengack, D. E. James, and G. E. Lienhard. 
1991. Translocafion of the glucose transporter GLUT4 in cardiac myo- 
cytes of the rat. Proc. Natl. Acad. Sci. USA. 88:7815-7819. 
37. Slot, J. W., H. J. Geuze, S. Gigengack, G. E. Lienhard, and D. E. James. 
1991. Immuno-localization of the insulin-regulatable glucose transporter 
in brown adipose tissue of the rat. J. Cell Biol. 113:123-135. 
38. Smith, R. M., M. J. Charron, N. Shah, H. F. Lodish, and L. Jarett. 1991. Im- 
munoelectron microscopic demonstration of insulin-stimulated translo- 
cation of glucose transporters to the plasma membrane of isolated rat ad- 
ipocytes and masking of the  carboxy-terminal epitope  of intracellular 
Glut4. Proc. Natl. Acad. Sci.  USA. 88:6893-6897. 
39. Tanner, L., and G. E. Lienhard. 1989. Localization of transferrin receptors 
and insulin-like  growth factor II receptors in vesicles from 3T3-L1 adipo- 
cytes that contain intracellular glucose transporters. J.  Cell Biol.  108: 
1537-1545. 
40. Thoidis, G., N.  Kotliar, and P.  F.  Pilch. 1993.  Immunological analysis of 
GLUT4-enriched vesicles. Identification of novel proteins regulated by 
insulin and diabetes. Z  Biol. Chem. 268:11691-11696. 
41. Tulp, A., D. Verwoerd, B. Dobberstein, H. L, Ploegh, and J. Pieters. 1994. 
Isolation and characterization of the intracellular mhc class II compart- 
ment. Nature (Lond.). 369:120-126. 
42.  Verhey, K. J., and M. J. Birnbaum. 1994. A  Leu-Leu sequence is essential 
to the C-terminal targeting signal of the GLUT4 glucose transport in fi- 
broblasts. ,L Biol. Chem. 269:2353-2356. 
43. Verhey, K. J., S. F. Hausdorff, and M. J. Birnbaum. 1993. Identification of 
the carboxy terminus as important for the isoform-specific subceUular 
targeting of glucose transporter proteins. J. Cell Biol. 123:137-147. 
44. Vilaro, S., M. Palacin, P. F. Pilch, X. Testar, and A. Zorzauo. 1989. Expres- 
sion of an insulin-regulatable glucose carrier in muscle and fat endothe- 
lial cells. Nature (Lond.). 342:798-800. 
45. Weiland, M., A. Schurmann, W. E. Schmidt, and H, G. Joost. 1990. Devel- 
opment of the hormone-sensitive glucose transport activity in differenti- 
ating 3TJ-L1 murine fibroblasts. Role of the two transporter species and 
their subcellular localization. Biochem. J. 270:331-336. 
46.  West, M.  A., J.  M. Lucocq, and C. Watts. 1994.  Antigen processing and 
class II mhc peptide-loading compartments in human B-lymphoblastoid 
cells. Nature (Lond.). 369:147-151. 
47. Yang, J., A. E. Clark, R. Harrison, I. J. Kozka, and G. D. Holman. 1992. 
Trafficking of glucose transporters in 3T3-L1 cells. Inhibition of traffick- 
ing by phenylarsine oxide implicates a slow dissociation of transporters 
from trafficking proteins. Biochem. J. 281:809-817. 
48. Yang, J., A. E. Clark, I. J. Kozka, S. W. Cushman, and G. D. Holman. 1992. 
Development of an intracellular pool of glucose transporters in 3TJ-L1 
cells. Z  Biol. Chem. 267:10393-10399. 
49. Yang, J., and G. D. Holman. 1993.  Comparison of GLUT4 and GLUT1 
subcenular trafficking in basal and  insulin-stimulated 3T3-L1  cells. J. 
Biol. Chem. 268:4601~4603. 
Verhey et al. Glucose Transport Targeting Signals  1079 